In addition, ChIP‐qPCR experiments were performed in MDA‐MB‐231 and HCC‐1806 cell lines to demonstrate that TET3 could bind to the IGF2BP3 promoter region (Figure S1k,l). This evidence concerns the gene IGF2BP3 and hepatocellular carcinoma.